Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

ABVD Versus Escalated Beacopp in Advanced Stage Hodgkin's Lymphoma: Results from a Retrospective, Multicenter European Study

Patrizia Mondello, MD PhD MSc, Irene Dogliotti, MD, Jan-Paul Bohn, Federica Cavallo, Simone Ferrero, MD, Barbara Botto, Claudio Cerchione, MD PhD, Davide Nappi, Sonya De Lorenzo, Giovanni Martinelli, MD, Dominik Wolf, Univ. Prof. Dr., Giacomo Loseto, MD, Salvatore Cuzzocrea, MD PhD, Wolfgang Willenbacher, MD PhD, Michael Mian, MD

Blood (2019) 134 (Supplement_1): 1565.

https://doi.org/10.1182/blood-2019-128198

Published: 2019

Journal Articles

Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL)

Blood (2018) 132 (Supplement 1): 401.

https://doi.org/10.1182/blood-2018-99-110289

Published: 2018

Journal Articles

Interferon Alpha, the New Old Disease Modifying Agent for Philadelphia-Negative Myeloproliferative Neoplasms

Patrizia Mondello, MD PhD MSc, Cristian Di Mirto, Carmela Arrigo, Vincenzo Pitini, MD, Michael Mian, MD

Blood (2018) 132 (Supplement 1): 3954.

https://doi.org/10.1182/blood-2018-99-114255

Published: 2018

Journal Articles

Identification of DNA Copy Number Variations Associated with the Clinical Outcome in Young Mantle Cell Lymphoma Patients Treated with Cytarabine-Based High Dose Sequential Chemotherapy and Autologous Stem Cell Transplantation in the Prospective from the MCL0208 Phase III Trial from Fondazione Italiana Linfomi (FIL)

Andrea Rinaldi, PhD, Simone Ferrero, Ivo Kwee, PhD, Davide Rossi, MD PhD, Alessio Bruscaggin, Valeria Spina, Fary Diop, Filippo Ballerini, MD, Filippo Gherlinzoni, MD, Fabio Benedetti, Michael Mian, MD, Caterina Stelitano, MD, Elisa Doni, MD, Alessandra Flavia Salvi, Sergio Cortelazzo, Marco Ladetto, MD, Gianluca Gaidano, MD PhD, Francesco Bertoni, MD

Blood (2016) 128 (22): 4099.

https://doi.org/10.1182/blood.V128.22.4099.4099

Published: 2016

Journal Articles

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, MD, Maria Giuseppina Cabras, MD, Caterina Patti, MD, Michael Mian, Renato Zambello, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alfonso D'Arco, Gianluca Doa, Marta Bruno-Ventre, Marco Foppoli, MD, Alessandro Fanni, MD, Antonino Mulè, MD, Fabio Ciceri, MD, Federico Caligaris-Cappio, MD

Blood (2014) 124 (21): 1724.

https://doi.org/10.1182/blood.V124.21.1724.1724

Published: 2014

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

Bendamustine in Chronic Lymphocytic Leukemia (CLL): Outcome According to Different Clinical and Biological Prognostic Factors in Everyday Practice

Francesco Zaja, Michael Mian, Carlo Visco, Cinzia Sissa, Ilaria Nichele, Monica Castelli, Achille Ambrosetti, Simona Puglisi, Renato Fanin, Sergio Cortelazzo, MD, Giovanni Pizzolo, MD, Livio Trentin, MD, Francesco Rodeghiero, Rossella Paolini, Paolo Vivaldi, Rosaria Sancetta, Gianpietro Semenzato

Blood (2012) 120 (21): 3922.

https://doi.org/10.1182/blood.V120.21.3922.3922

Published: 2012

Journal Articles

Large Genomic Aberrations Are Independent Prognosticators of A Shorter Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia (CLL) Patients with A Normal FISH

Michael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, Davide Rossi, MD, Marco Ladetto, MD, Francesco Forconi, Roberto Marasca, MD, Mario Uhr, MD, Georg Stussi, MD, Ivo Kwee, Franco Cavalli, MD, Gianluca Gaidano, MD, PhD, Emanuele Zucca, MD, Francesco Bertoni, MD

Blood (2012) 120 (21): 3906.

https://doi.org/10.1182/blood.V120.21.3906.3906

Published: 2012

Journal Articles

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Blood (2011) 117 (5): 1595–1604.

https://doi.org/10.1182/blood-2010-01-264275

Published: 2011

Includes: Supplemental data

Journal Articles

Retrospective Analysis of 206 Mantle Cell Lymphoma Patients at Diagnosis: Mantle Cell International Prognostic Index (MIPI) Is a Good Predictor of Death Event In Patients Treated Either with Rituximab-Chemotherapy or Rituximab-High-Dose-Chemotherapy

Blood (2010) 116 (21): 1784.

https://doi.org/10.1182/blood.V116.21.1784.1784

Published: 2010

Journal Articles

High Resolution Array-CGH Provides New Insights Into the Prognosis of Chronic Lymphocytic Leukemia (CLL): Is 8p Loss Worse Than 17p Loss?.

Andrea Rinaldi, Michael Mian, MD, Davide Rossi, MD, Francesco Forconi, Clara Deambrogi, PhD, Valeria Spina, PhD, Emanuele Cencini, Elisa Sozzi, BSci, Daniela Drandi, PhD, Marco Ladetto, Rita Santachiara, Roberto Marasca, Ekaterina Chigrinova, MD, Franco M.D. Cavalli, Valter Gattei, Emanuele Zucca, Gianluca Gaidano, MD, Ivo Kwee, Francesco Bertoni, MD

Blood (2009) 114 (22): 2339.

https://doi.org/10.1182/blood.V114.22.2339.2339

Published: 2009

Journal Articles

Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.

Blood (2009) 114 (22): 3957.

https://doi.org/10.1182/blood.V114.22.3957.3957

Published: 2009

Journal Articles

SNP-Arrays Provide New Insights Into the Pathogenesis of Post-Transplant Diffuse Large B-Cell Lymphoma (PT-DLBCL).

Andrea Rinaldi, Daniela Capello, PhD, Marta Scandurra, Timothy C. Greiner, MS, MD, Wing C. Chan, Davide Rossi, MD, Govind Bhagat, Marco Paulli, MD, Giorgio Inghirami, Maurilio Ponzoni, Santiago Montes Moreno, Miguel A. Piris, MD, Michael Mian, MD, Paola M.V. Rancoita, Emanuele Zucca, Riccardo Dalla-Favera, Gianluca Gaidano, MD, Ivo Kwee, Francesco Bertoni, MD

Blood (2009) 114 (22): 444.

https://doi.org/10.1182/blood.V114.22.444.444

Published: 2009

Journal Articles

Identification of New Recurrent Multiple Small Interstitial Deletions Affecting Genes Coding for Kinases in Chronic Lymphocytic Leukemia (CLL): a New Pathogenic Mechanism?.

Andrea Rinaldi, Michael Mian, MD, Davide Rossi, MD, Francesco Forconi, Clara Deambrogi, PhD, Valeria Spina, PhD, Emanuele Cencini, Elisa Sozzi, BSci, Daniela Drandi, Marco Ladetto, Rita Santachiara, Roberto Marasca, Ekaterina Chigrinova, MD, Franco Cavalli, M.D., Valter Gattei, MD, Emanuele Zucca, Gianluca Gaidano, MD, PhD, Ivo Kwee, Francesco Bertoni, MD

Blood (2009) 114 (22): 672.

https://doi.org/10.1182/blood.V114.22.672.672

Published: 2009

Journal Articles

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Blood (2008) 112 (11): 3608.

https://doi.org/10.1182/blood.V112.11.3608.3608

Published: 2008

Journal Articles

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Blood (2007) 110 (11): 3432.

https://doi.org/10.1182/blood.V110.11.3432.3432

Published: 2007

Journal Articles

Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma

Sergio Cortelazzo, MD, Michele Magni, MD, Corrado Tarella, MD, Michael Mian, MD, Atto Billio, MD, Andrea Rossi, MD, Maddalena Marchesi, MD, Andrea Gallamini, MD, Paolo Corradini, MD, Fabio Ciceri, MD, Guido Parvis, MD, Ignazio Majolino, MD, Caterina Patti, MD, Salvo Mirto, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD

Blood (2007) 110 (11): 1282.

https://doi.org/10.1182/blood.V110.11.1282.1282

Published: 2007

Journal Articles

Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: The Northern Italy Leukemia Group (NILG) Experience.

Irene M. Cavattoni, MD, Enrico Morello, MD, Michael Mian, MD, Elena Oldani, Biol.Sc., Tamara Intermesoli, MD, Erika Borlenghi, MD, Giuseppe Rossi, MD, Claudia Minotto, MD, Elisabetta Terruzzi, MD, Enrico Maria Pogliani, Ernesta Audisio, MD, Filippo Marmont, MD, Alessandro Rambaldi, MD, Renato Bassan, MD, Sergio Cortelazzo, MD

Blood (2006) 108 (11): 5380.

https://doi.org/10.1182/blood.V108.11.5380.5380

Published: 2006

Journal Articles

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).

Sergio Cortelazzo, MD, Michele Magni, MD, Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Atto Billio, MD, Maddalena Marchesi, MD, Manuela Zanni, MD, Corrado Tarella, MD, Mario Boccadoro, MD, Angelo Andreini, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Tiziano Barbui, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3045.

https://doi.org/10.1182/blood.V108.11.3045.3045

Published: 2006

NARROW

ABVD Versus Escalated Beacopp in Advanced Stage Hodgkin's Lymphoma: Results from a Retrospective, Multicenter European Study

Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL)

Interferon Alpha, the New Old Disease Modifying Agent for Philadelphia-Negative Myeloproliferative Neoplasms

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Bendamustine in Chronic Lymphocytic Leukemia (CLL): Outcome According to Different Clinical and Biological Prognostic Factors in Everyday Practice

Large Genomic Aberrations Are Independent Prognosticators of A Shorter Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia (CLL) Patients with A Normal FISH

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Retrospective Analysis of 206 Mantle Cell Lymphoma Patients at Diagnosis: Mantle Cell International Prognostic Index (MIPI) Is a Good Predictor of Death Event In Patients Treated Either with Rituximab-Chemotherapy or Rituximab-High-Dose-Chemotherapy

SNP6 Array Better Defines Chronic Lymphocytic Leukemia (CLL) Prognostic Groups

High Resolution Array-CGH Provides New Insights Into the Prognosis of Chronic Lymphocytic Leukemia (CLL): Is 8p Loss Worse Than 17p Loss?.

Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.

SNP-Arrays Provide New Insights Into the Pathogenesis of Post-Transplant Diffuse Large B-Cell Lymphoma (PT-DLBCL).

Identification of New Recurrent Multiple Small Interstitial Deletions Affecting Genes Coding for Kinases in Chronic Lymphocytic Leukemia (CLL): a New Pathogenic Mechanism?.

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma

Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: The Northern Italy Leukemia Group (NILG) Experience.

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only